Laying the Tracks: Connecting the Fragments of Rare Disease Data

I spent years in IT at a national rare disease organization, and I have two brothers with rare genetic conditions. Because of that, I've been on both sides of the rare disease information problem: the side that desperately needs the data, and the side that tries to provide it.

KISHO exists because the infrastructure for rare disease intelligence didn't exist and needed to. Not the organizations. Not the expertise. Not the trust networks. The infrastructure. The railroad that connects all of it.

A railroad doesn't grow the grain, build the furniture, or brew the beer. It moves the goods. It connects places that were previously hard to reach. It makes the people who produce things more effective by solving the distribution problem so they can focus on the production problem.

That's what KISHO does. It connects trusted government and scientific databases across 10,888+ rare diseases and makes the information structured, current, and accessible. The people who produce the knowledge, who interpret the data, who serve the communities? They bring the goods. KISHO is the rail.

When you build a platform at this scale, people naturally wonder what you're trying to replace. The answer is highly specific: KISHO replaces the hours that smart, overworked people currently spend manually searching ClinicalTrials.gov, PubMed, FDA databases, NIH RePORTER, and state legislative trackers. It replaces the tangled spreadsheets. It replaces the Monday morning ritual of checking five different government websites just to copy and paste into a newsletter draft.

It does not replace the people.

Your Clinician

KISHO is not a diagnostic tool. It is not a treatment recommendation engine. If you search for a disease on KISHO, you'll see its clinical trials, approved therapies, research publications, and policy activity. Every data point traces back to a primary source you can verify.

Interpreting that data for a specific patient in a specific clinical situation is a clinician's job. KISHO gives patients and families better access to the landscape of their disease, but the conversation about what to do with that information belongs in a doctor's office, not on a platform.

Your Medical Writer

Medical writing is not just summarization. A medical writer constructing an FDA submission or a clinical study report is making regulatory arguments backed by scientific evidence. That requires training, experience with FDA expectations, and professional accountability.

KISHO eliminates the manual data-gathering phase. A medical writer working on a rare disease program can pull every active and completed trial, every orphan designation, every approved therapy, and every relevant publication from a single structured view. That turns hours of searching into minutes. But the document they produce from that data relies on their expertise, not ours.

Your Patient Advocacy Group (PAG)

A patient advocacy group that has spent ten years building relationships with 300 families, running an annual conference, staffing a helpline, and advocating for newborn screening inclusion has something that cannot be replicated by a database: Trust. Institutional memory. Community.

KISHO is built to serve PAGs, not to compete with them. The value proposition is straightforward: a PAG staff member who currently spends 8 to 10 hours a week gathering disease intelligence from scattered sources can reclaim almost all of those hours. Our surveillance tools track trials, publications, policy, and news automatically. That time goes right back into the work that only they can do—serving their community. I know what PAGs actually do because I watched them do it. I saw the gap between the data these groups needed and the tools they had to find it. That gap is what KISHO exists to close.

Your Umbrella Organizations

Large national and international rare disease organizations do work that goes far beyond information. They run patient assistance programs, operate helplines, lobby Congress, and coordinate across hundreds of disease communities. They convene industry, academia, and advocacy in ways that shape policy and accelerate research.

None of that is a data problem. All of it is harder and more important than anything a platform can do. KISHO simply makes the intelligence layer underneath those functions faster and more reliable. A staffer preparing for a Hill meeting can pull a structured policy briefing for a disease area in minutes instead of manually tracking state and federal bills. But the meeting itself, the relationships, the advocacy strategy? That's institutional work. No railroad replaces the factories it serves.

MONDO and Scientific Foundations

Every disease in KISHO maps to a MONDO identifier. MONDO provides the ontological structure, the disease hierarchy, and the cross-references to OMIM, Orphanet, and ICD codes that make everything else possible. Without MONDO, KISHO could not connect a disease to its trials, genes, or therapies in a verified, structured way.

KISHO is a consumer of MONDO, not a competitor. The same is true for HPO (phenotype data), HGNC (gene nomenclature), and every other foundational scientific resource the platform depends on. The researchers who maintain those ontologies are doing work that KISHO could not replicate and has no intention of trying. We simply make those scientific structures useful to people who need disease intelligence but aren't going to query an OWL file. The accuracy of our platform depends entirely on their foundational work.

The Bottom Line

KISHO is the railroad. It connects twelve data sources across 10,888 diseases and keeps the information moving: current, structured, and accessible. It turns hours of manual search into seconds of structured intelligence.

The people and organizations who do the work that matters in rare disease—the clinicians, the writers, the advocates, the scientists, and the PAG leaders who answer the phone at 9 PM—are the ones producing the goods. KISHO doesn't replace what they carry. It just gives them a better track to carry it on.

Stop digging for data and start using it. Book a demo today to see how KISHO can give your team its time back.